Schisandrin B protects against angiotensin II-induced endotheliocyte deficits by targeting Keap1 and activating Nrf2 pathway
Jibo Han(Jiaxing University), Jianjiang Xu(Jiaxing University)
Cited by 19
Related Papers
Wogonin Inhibits Cardiac Hypertrophy by Activating Nrf-2-Mediated Antioxidant Responses
|Cardiovascular Therapeutics|2021|33
DL-3-n-Butylphthalide Attenuates Myocardial Hypertrophy by Targeting Gasdermin D and Inhibiting Gasdermin D Mediated Inflammation
|Frontiers in Pharmacology|2021|23